
    
      The investigators will collect 90 cases which will be divided into 3 groups. Patients in
      Group A will receive scalp nerve block and patient-controlled analgesia which contains
      sufentanil and ondansetron. In Group B, patient-controlled analgesia which contains
      sufentanil, ondansetron and ketamine will be applied. In Group C, patient-controlled
      analgesia which contains sufentanil and ondansetron will be applied.
    
  